Catalyst Wire Dossier Catalyst Wire Dossier

ddC

dideoxycytidine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ddC, covering 2021-11-03 to 2021-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3 [Phase 2]

See pricing